Inside the human cancer tyrosine phosphatome

Authors:

Abstract
The protein tyrosine phosphatase (Ptp) family comprises 107 members that are classified into four classes on the basis of the amino acid sequences of their catalytic domains. Recent evidence has shown that members of the Ptp family are key components of tumorigenesis in various human cancers, exerting either putative oncogenic or tumour suppressive functions, depending on the cellular context. Genetic alterations such as mutation, deletion and amplification are the most important features for putative oncogenic PTPs, whereas in most cases epigenetic modifications such as DNA methylation counter the tumour suppressive functions of PTPs. Recent advances have begun to decipher the molecular mechanisms by which putative oncogenic PTPs may drive tumorigenesis in human cells. Proliferation, survival, apoptosis, vesicular trafficking, adhesion, migration and invasion are all altered by the aberrant functions of PTPs during tumour development. Evidence for an association between PTPs and an increased risk of developing cancer remains controversial and elusive. Here, we focus on the pertinent genetic and functional data that support the relevance of members of the Ptp family to human cancer. PTP inhibitors are currently being developed. However, a better understanding of the basic biology of PTPs in human tumour development will be required to improve the therapeutic use of such inhibitors.

This publication has 193 references indexed in Scilit: